Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2001-11-0026PMID 12239171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

  2001influential reference
• Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia

  2001influential reference
• Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells.

  2000influential reference
• p57 Is Not Mutated in Hepatoblastoma but Shows Increased Transcriptional Activity in a Comparative Analysis of the Three Imprinted Genes p57, IGF2, and H19

  2000influential reference
• p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.

  2000influential reference
• Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation.

  2000influential reference
• Decreased expression of p57KIP2mRNA in human bladder cancer

  2000cited by this paper
• Erratum: LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids (Human Molecular Genetics (1999) 8 (1209-1217))

  1999cited by this paper
• LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids.

  1999influential reference
• p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing.

  1999influential reference
• Expression of cell cycle regulatory genes in chronic myelogenous leukemia.

  1998influential reference
• p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.

  1998influential reference
• Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cells

  1998cited by this paper
• Role of the p16 tumor suppressor gene in cancer.

  1998influential reference
• Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome

  1997influential reference
• Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.

  1997influential reference
• Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.

  1996influential reference
• Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.

  1996influential reference
• Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors.

  1996influential reference
• An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome

  1996cited by this paper
• Characterization of the human p57KIP2 gene: Alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis

  1996cited by this paper
• Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.

  1996influential reference
• Cyclin D1 protein expression in mantle cell lymphoma.

  1995influential reference
• Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

  1995influential reference
• Genomic imprinting of p57KIP2, a cyclin–dependent kinase inhibitor, in mouse

  1995influential reference
• Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

  1995influential reference
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

  1994influential reference
• pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest

  1994cited by this paper
• Absence of WAF1 mutations in a variety of human malignancies.

  1994influential reference
• Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias.

  1994influential reference
• p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

  1994cited by this paper
• G1 phase progression: cycling on cue.

  1994cited by this paper
• Genomic imprinting: mechanism and role in human pathology.

  1994influential reference
• Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit

  1993influential reference
• WAF1, a potential mediator of p53 tumor suppression.

  1993influential reference
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993influential reference
• Beckwith-Wiedemann Syndrome, Tumorigenesis and Imprinting

  1992influential reference
• Beckwith-Wiedemann syndrome, tumourigenesis and imprinting.

  1992cited by this paper
• Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.

  1991influential reference
• Allelotype study of primary hepatocellular carcinoma.

  1991influential reference
• Genetic Alteration of p53 in Some Patients with Adult T‐Cell Leukemia

  1991influential reference
• Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

  1989influential reference
• Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.

  1989influential reference
• Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.

  1986influential reference
• Loss of genes on the short arm of chromosome 11 in bladder cancer

  1985influential reference

• NanoBubble-Mediated Oxygenation: Elucidating the Underlying Molecular Mechanisms in Hypoxia and Mitochondrial-Related Pathologies

  2023cites this paper
• Supplement for: Sufficient principal component regression for pattern discovery in transcriptomic data

  2022cites this paper
• Cyclin-dependent kinase inhibitors in malignant hematopoiesis

  2022cites this paper
• Loss of MBD2 attenuates MLL-AF9-driven leukemogenesis by suppressing the leukemic cell cycle via CDKN1C

  2021cites this paper
• Protein and genetic expression of CDKN1C and IGF2 and clinical features related to human umbilical cord length

  2020cites this paper
• METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.

  2020cites this paper
• Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma

  2019cites this paper
• Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57KIP2 and involving in p‐p38 MAPK and NF‐κB pathways

  2018cites this paper
• Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases

  2018cites this paper
• DNA methylation marks in peripheral blood and the risk of developing mature B cell neoplasms

  2018cites this paper
• RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas

  2018cites this paper
• Targeting Epigenetic Modifiers for Cancer Treatments

  2018cites this paper
• Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression

  2017cites this paper
• Oxygen nanobubbles revert hypoxia by methylation programming

  2017cites this paper
• Suppression of miR-708 inhibits the Wnt/β-catenin signaling pathway by activating DKK3 in adult B-all

  2017cites this paper
• Genomic Imprinting Syndromes and Cancer

  2017cites this paper
• The Genetic Basis of Haematological Cancers: Tosi/The Genetic Basis of Haematological Cancers

  2016cites this paper
• Aberrant p15, p16, p53, and DAPK Gene Methylation in Myelomagenesis: Clinical and Prognostic Implications.

  2016cites this paper
• Aberrant p 15 , p 16 , p 53 , and DAPK Gene Methylation in Myelomagenesis : Clinical and Prognostic Implications

  2016cites this paper
• The genetics of mature B-cell malignancies

  2016cites this paper
• Methylation status of the promoter region of the human frizzled 9 gene in acute myeloid leukemia.

  2016cites this paper
• A cross-talk between DNA methylation and H3 lysine 9 dimethylation at the KvDMR1 region controls the induction of Cdkn1c in muscle cells

  2016cites this paper
• Physiological and pathological implications of 5-hydroxymethylcytosine in diseases

  2016cites this paper
• Prognostic relevance of aberrant SOCS‐1 gene promoter methylation in myelodysplastic syndromes patients

  2015cites this paper
• DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma

  2015cites this paper
• Chapter 28 – Personalized Epigenetic Therapy—Chemosensitivity Testing

  2015cites this paper
• Imprinted genes in myeloid lineage commitment in normal and malignant hematopoiesis

  2015cites this paper
• Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments.

  2015cites this paper
• Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells

  2015cites this paper
• MicroRNA-21 inhibits p57Kip2 expression in prostate cancer

  2014influential citation
• SHORT COMMUNICATION Open Access MicroRNA-21 inhibits p57 Kip2 expression in prostate cancer

  2014cites this paper
• 6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells

  2014cites this paper
• Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma

  2014cites this paper
• Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker.

  2014cites this paper
• clinicopathological significance and potential drug target of p15 INK4B in multiple myeloma

  2014cites this paper
• The Diagnostic Value of DNA Methylation in Leukemia: A Systematic Review and Meta-Analysis

  2014influential citation
• Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.

  2013cites this paper
• mRNA expression and promoter DNA methylation status of CDKi p21 and p57 genes in ex vivo expanded CD34+ cells following co-culture with mesenchymal stromal cells and growth factors

  2013cites this paper
• Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma

  2013cites this paper
• Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOP.

  2013cites this paper
• Role of DNA methylation in the pathogenesis and treatment of myelodysplastic syndromes.

  2013cites this paper
• Expression and epigenetic regulation of imprinted genes in prostate cancer

  2013cites this paper
• An integrated microfluidic platform for rapid tumor cell isolation, counting and molecular diagnosis

  2013cites this paper
• Abnormal DLK1/MEG3 imprinting correlates with decreased HERV-K methylation after assisted reproduction and preimplantation genetic diagnosis

  2013cites this paper
• Risk Factors of Follicular Lymphoma.

  2012cites this paper
• Cell cycle regulatory molecular profiles of pediatric T-cell lymphoblastic leukemia and lymphoma

  2012cites this paper
• Characterization, Tissue Expression, and Imprinting Analysis of the Porcine CDKN1C and NAP1L4 Genes

  2012cites this paper
• The hallmarks of CDKN1C (p57, KIP2) in cancer.

  2011cites this paper
• Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.

  2011cites this paper
• EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo

  2011cites this paper
• p57 and Cancer: Time for a Critical Appraisal

  2011cites this paper
• Pathology, pathogenesis and molecular genetics of follicular NHL.

  2011cites this paper
• p57Kip2 and Cancer: Time for a Critical Appraisal

  2011cites this paper
• Epigenetic silencing of cell cycle regulatory genes during 3‐methylcholanthrene and diethylnitrosamine‐induced multistep rat lung cancer

  2010cites this paper
• DNA methylation in follicular lymphoma

  2010cites this paper
• Aberrant DNA methylation of the p57KIP2 gene is a sensitive biomarker for detecting minimal residual disease in diffuse large B cell lymphoma.

  2010cites this paper
• Molecular targets for epigenetic therapy of cancer.

  2009cites this paper
• Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.

  2009cites this paper
• The regulation of p 21 Waf 1 / Cip 1 , p 27 Kip 1 and p 57 Kip 2 gene expression in response to hydrocortisone , progesterone and ß-estradiol in HL-60 myeloid leukemia cells

  2009cites this paper
• SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.

  2009cites this paper
• Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma.

  2009cites this paper
• p57KIP2: “Kip”ing the Cell under Control

  2009cites this paper
• CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF‐P

  2009cites this paper
• Prognostic significance of O6‐methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B‐cell lymphomas

  2009cites this paper
• CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells

  2009cites this paper
• p 57 KIP 2 : “ Kip ” ing the Cell under Control

  2009cites this paper
• Large scale CpG island methylation profiling of small B cell lymphoma

  2008cites this paper
• Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.

  2008cites this paper
• The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms

  2008cites this paper
• Novel epigenetic targets in lymphoproliferative disorders.

  2008cites this paper
• Mechanisms of Cell Cycle Regulation by TGF-β Disabled in Cancer

  2008cites this paper
• Bortezomib (PS‐341) in patients with human herpesvirus 8‐associated primary effusion lymphoma

  2008cites this paper
• Epimutations of the KCNQ1OT1 imprinting center of chromosome 11 in early human embryolethality

  2008cites this paper
• Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma.

  2007cites this paper
• DNAse I pre-treatment markedly enhances detection of nuclear cyclin-dependent kinase inhibitor p57Kip2 and BrdU double immunostaining in embryonic rat brain

  2007cites this paper
• Intensifled Doxorubicin-Based Regimen E-cacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement

  2007cites this paper
• Relational Analysis of CpG Islands Methylation and Gene Expression in Human Lymphomas Using Possibilistic C-Means Clustering and Modified Cluster Fuzzy Density

  2007cites this paper
• EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase.

  2007cites this paper
• Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.

  2007cites this paper
• Combining array‐based approaches for the identification of candidate tumor suppressor loci in mature lymphoid neoplasms

  2007cites this paper
• EHA Scientific Workshop Report: The Role of Epigenetics in Hematological Malignancies

  2007cites this paper
• Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.

  2007cites this paper
• CpG Island Methylation and Drug Resistance

  2006cites this paper
• Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review

  2006cites this paper
• Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.

  2006cites this paper
• Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours

  2006cites this paper
• Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer

  2006influential citation
• The fundamental role of epigenetics in hematopoietic malignancies.

  2006cites this paper
• Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior

  2006cites this paper
• Expression of p57-Kip2 in monocytes and macrophages.

  2006cites this paper
• Methylation of p16INK4A and p57KIP2 are involved in the development and progression of gastric MALT lymphomas

  2006cites this paper
• p57kip2 expression is related to carcinogenesis and tumor progression in laryngeal tissues

  2006cites this paper
• Downregulation of the KIP family members p27KIP1 and p57KIP2 by SKP2 and the role of methylation in p57KIP2 inactivation in nonsmall cell lung cancer

  2006influential citation
• Untersuchungen zur aberranten DNA-Methylierung in humanen myeloischen Neoplasien mit Hilfe hochauflösender quantitativer Analysemethoden

  2006cites this paper
• Alternative mechanisms associated with silencing of CDKN1C in Beckwith–Wiedemann syndrome

  2005cites this paper
• Absence of p21CIP1, p27KIP1 and p57KIP2 methylation in MDS and AML

  2005cites this paper
• ABERRANT EPIGENETICS IN THE MOLECULAR PATHOGENESIS OF HUMAN ACUTE MYELOID LEUKEMIA

  2005cites this paper
• Infrequent epigenetic dysregulation of CIP/KIP family of cyclin-dependent kinase inhibitors in multiple myeloma

  2005cites this paper
• Myelodysplastic syndromes: clinicopathologic features, pathobiology, and molecular pathogenesis.

  2005cites this paper
• Childhood and adult ALL: Differences in epigenetic lesions associated with cell cycle genes

  2005cites this paper